JNJ

239.99

+0.58%↑

UNH

273.88

-1.05%↓

TMO

541.25

-1.25%↓

ABT

112.24

+1.31%↑

ISRG

497.33

+0.87%↑

JNJ

239.99

+0.58%↑

UNH

273.88

-1.05%↓

TMO

541.25

-1.25%↓

ABT

112.24

+1.31%↑

ISRG

497.33

+0.87%↑

JNJ

239.99

+0.58%↑

UNH

273.88

-1.05%↓

TMO

541.25

-1.25%↓

ABT

112.24

+1.31%↑

ISRG

497.33

+0.87%↑

JNJ

239.99

+0.58%↑

UNH

273.88

-1.05%↓

TMO

541.25

-1.25%↓

ABT

112.24

+1.31%↑

ISRG

497.33

+0.87%↑

JNJ

239.99

+0.58%↑

UNH

273.88

-1.05%↓

TMO

541.25

-1.25%↓

ABT

112.24

+1.31%↑

ISRG

497.33

+0.87%↑

Search

Smith & Nephew PLC ADR

Открыт

35.38 1.55

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

34.67

Макс.

35.47

Ключевые показатели

By Trading Economics

Доход

296M

Продажи

3B

P/E

Средняя по отрасли

30.589

84.243

Дивидендная доходность

2.22

Рентабельность продаж

9.895

Сотрудники

17,000

EBITDA

723M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

-0.66% downside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.22%

2.28%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

15B

Предыдущая цена открытия

33.83

Предыдущая цена закрытия

35.38

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

9 февр. 2026 г., 17:25 UTC

Приобретения, слияния, поглощения

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

9 февр. 2026 г., 23:46 UTC

Обсуждения рынка

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

9 февр. 2026 г., 23:43 UTC

Обсуждения рынка

Gold Falls on Possible Technical Correction -- Market Talk

9 февр. 2026 г., 23:14 UTC

Обсуждения рынка

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

9 февр. 2026 г., 22:29 UTC

Обсуждения рынка

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

9 февр. 2026 г., 22:19 UTC

Обсуждения рынка

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

9 февр. 2026 г., 22:08 UTC

Обсуждения рынка

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

9 февр. 2026 г., 22:01 UTC

Отчет

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

9 февр. 2026 г., 21:59 UTC

Отчет

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

9 февр. 2026 г., 21:59 UTC

Отчет

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

9 февр. 2026 г., 21:58 UTC

Отчет

Friedman Industries 3Q Sales $168M >FRD

9 февр. 2026 г., 21:50 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Financial Services Roundup: Market Talk

9 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

9 февр. 2026 г., 21:48 UTC

Отчет

Friedman Industries 3Q EPS 43c >FRD

9 февр. 2026 г., 21:17 UTC

Отчет

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

9 февр. 2026 г., 21:13 UTC

Обсуждения рынка

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

9 февр. 2026 г., 21:04 UTC

Отчет

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

9 февр. 2026 г., 20:30 UTC

Обсуждения рынка

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

9 февр. 2026 г., 20:02 UTC

Обсуждения рынка

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

9 февр. 2026 г., 19:42 UTC

Обсуждения рынка

Japan's Yield Curve Expected to Flatten -- Market Talk

9 февр. 2026 г., 19:31 UTC

Обсуждения рынка

Nike Seen Regaining Relevance With Consumers -- Market Talk

9 февр. 2026 г., 19:27 UTC

Обсуждения рынка

Gold Climbs Back Over $5,000/oz -- Market Talk

9 февр. 2026 г., 19:05 UTC

Обсуждения рынка

Nike Returns to List of Hottest Brands -- Market Talk

9 февр. 2026 г., 18:19 UTC

Обсуждения рынка

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

9 февр. 2026 г., 17:41 UTC

Отчет
Приобретения, слияния, поглощения

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

9 февр. 2026 г., 17:31 UTC

Отчет
Приобретения, слияния, поглощения

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

9 февр. 2026 г., 17:20 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Financial Services Roundup: Market Talk

9 февр. 2026 г., 17:20 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

9 февр. 2026 г., 17:17 UTC

Обсуждения рынка

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

9 февр. 2026 г., 17:16 UTC

Отчет

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

-0.66% падение

Прогноз на 12 месяцев

Средняя 34.46 USD  -0.66%

Максимум 34.91 USD

Минимум 34 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat